ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Glenmark Pharmaceuticals Limited Complete list of announcements declared & dividend announcements by Glenmark Pharmaceuticals Limited GLENMARK

Glenmark Pharmaceuticals Limited GLENMARK listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Glenmark Pharmaceuticals Limited GLENMARK

Company Announcement
Glenmark Pharmaceuticals Launches GLIPIQⓇ (Semaglutide) In India. Setting a new benchmark in affordability for GLP-1 therapy, with weekly treatment starting at ₹325.
Announcement as on 23 March 2026

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 16, 2026, titled "Glenmark Pharmaceuticals Inc., USA to launch
Announcement as on 16 March 2026

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 04, 2026, titled "Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Compet
Announcement as on 04 March 2026

Glenmark Pharmaceuticals wins USFDA nod for fluticasone inhaler
Glenmark Pharmaceuticals has secured a significant approval from the US FDA for its inhaler fluticasone propionate. This marks a key step in strengthening the company's respiratory offerings in the US market. The product is set for distribution starting Ma
Announcement as on 04 March 2026

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 27, 2026, titled "Glenmark Pharmaceuticals Inc., USA to launch Sodium Phosphates Injection USP,
Announcement as on 27 February 2026

Announcements by Glenmark Pharmaceuticals Limited first page | Next page | Prev page |

GLENMARK Glenmark Pharmaceuticals Limited current price & indicator signals

Moving Averages for Glenmark Pharmaceuticals Limited

  • 5Day Average: 2318.6
  • 12Day Average: 2304.73
  • 20Day Average: 2275.57
  • 50Day Average: 2240.11
  • 100Day Average: 2252.49
  • 150Day Average: 2187.3
  • 200Day Average: 2127.92

GLENMARK Indicators & signals

Indicator MACD (12,26,9)

2307.43, 2279.76, 19.23
Indicator MACD is in positive zone

Indicator ADX (14)

14.41, 20.63, 15.43
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GLENMARK Glenmark Pharmaceuticals Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
24 Mon Aug 2026 2390.70 2295.30 to 2395.00 3.14% 1.63 times
21 Fri Aug 2026 2317.90 2303.00 to 2348.60 -0.64% 0.54 times
20 Thu Aug 2026 2332.90 2252.10 to 2342.00 3.85% 1.27 times
19 Wed Aug 2026 2246.50 2222.50 to 2313.90 -2.54% 1.91 times
18 Tue Aug 2026 2305.00 2305.00 to 2332.90 -1.03% 0.87 times
17 Mon Aug 2026 2329.00 2300.00 to 2337.00 0.46% 0.7 times
14 Fri Aug 2026 2318.40 2307.20 to 2341.60 -0.07% 1.44 times
13 Thu Aug 2026 2320.00 2281.90 to 2322.90 1.31% 0.95 times
12 Wed Aug 2026 2290.00 2272.40 to 2310.00 0.62% 1.07 times
11 Tue Aug 2026 2276.00 2245.00 to 2291.00 1.1% 0.65 times
10 Mon Aug 2026 2251.30 2251.30 to 2297.80 -1.22% 0.59 times
07 Fri Aug 2026 2279.10 2256.00 to 2289.00 0.4% 1 times

Videos related to: GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

 

Back to top